Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackstone Loan Regulatory News (BGLF)

Share Price Information for Blackstone Loan (BGLF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.57
Bid: 0.55
Ask: 0.59
Change: 0.00 (0.00%)
Spread: 0.04 (7.273%)
Open: 0.57
High: 0.57
Low: 0.57
Prev. Close: 0.57
BGLF Live PriceLast checked at -
Blackstone/GSO Loan Financing is an Investment Trust

To provide shareholders with stable and growing income returns, and to grow the capital value of the investment portfolio by exposure to all debt tranches of CLOs (CLO Income Notes and other CLO Securities) and in Loan Warehouses.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

20 Oct 2023 07:00

RNS Number : 7296Q
Blackstone Loan Financing Limited
20 October 2023
 

Blackstone Loan Financing Limited

20 October 2023

Net Asset Value and Publication of Monthly Report

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN.

As at the close of business on 30 September 2023, the unaudited net asset value per Euro Ordinary Share of Blackstone Loan Financing Limited ("BGLF") is as set out below:

BGLF Share class

NAV per Share

Change in Monthly NAV per share (Euro)

Monthly Performance (Euro)

Euro Ordinary Share

EUR 0.9031 / GBP 0.7826(1)

2.00%

2.00%

 

(1) As at 30 September 2023, using an exchange rate of EUR 1: GBP 0.8666. The GBP equivalent of the unaudited net asset value per Euro Ordinary Share has been presented for information purposes only.

 

Monthly Report

BGLF also announces today that the BGLF Monthly Report for September 2023, along with a market update supplement, will be available at the following link under "Monthly Reports":

 

http://blackstone.com/bglf

 

Within the BGLF monthly report, you will also find supplementary valuation information for the Company's NAV, where CLO Income Note valuations are shown using both a 'mark to model' and 'mark to market' approach, both of which have been provided by our third party valuation agent. This comparison has historically been shared twice per year within our annual and interim reports, and is now included on a more frequent quarterly basis, positioned on page 5 of the monthly report.

 

Investor Call

We invite you to join members of the BGLF Board and Blackstone Credit for an update call on Wednesday 15 November 2023, at 14:30 BST by registering beforehand using the below link:

 

https:/webcast.openbriefing.com/bglf-3q-23

 

Please email questions in advance to Investor.Relations@singercm.com

 

NOTE: PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE PERFORMANCE RESULTS AND THERE CAN BE NO ASSURANCE THAT BGLF WILL ACHIEVE COMPARABLE RESULTS.

 

IMPORTANT INFORMATION

Any reference herein to future returns or distributions is a target and not a forecast and there can be no guarantee or assurance that it will be achieved.

This document has been issued by Blackstone Loan Financing Limited (the "Company"), and should not be taken as an offer, invitation or inducement to engage in any investment activity and is solely for the purpose of providing information about the Company. This document does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any share in the Company or securities in any other entity, in any jurisdiction, including the United States, Canada, Japan or South Africa nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with, any contract or investment decision whatsoever, in any jurisdiction.

This document, and the information contained therein, is not for viewing, release, distribution or publication in or into the United States, Canada, Japan, South Africa or any other jurisdiction where applicable laws prohibit its release, distribution or publication, and will not be made available to any national, resident or citizen of the United States, Canada, Japan or South Africa. The distribution of this document in other jurisdictions may be restricted by law and persons into whose possession this document comes must inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the federal securities law of the United States and the laws of other jurisdictions.

The Company has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act") and, as such, holders of the Shares will not be entitled to the benefits of the Investment Company Act. The shares issued by the Company (the "Shares") have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States. The Shares may not be offered, sold, resold, pledged, taken up, exercised, renounced, delivered, distributed or otherwise transferred, directly or indirectly, into or within the United States, or to, or for the account or benefit of, US persons (as defined in Regulation S under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States and in a manner which would not require the Company to register under the Investment Company Act. No public offering of the Shares is being made in the United States.

In addition, the Shares are subject to restrictions on transferability and resale in certain jurisdictions and may not be transferred or resold except as permitted under applicable securities laws and regulations. Investors may be required to bear the financial risks of their investment in the Shares for an indefinite period of time. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdictions.

 

This document may contain forward-looking statements that represent the Company's opinions, expectations, beliefs, intentions, estimates or projections. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology. Any statement other than a statement of historical fact is a forward-looking statement. By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not outside the control of the Company. Actual results may differ materially from those expressed or implied by any forward-looking statement and even if the results of the Company are consistent with such forward-looking statement, those results may not be indicative of results in subsequent periods. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Recipients of this document should not place undue reliance on any forward-looking statement, which speaks only as of the date of its issuance.

No liability whatsoever (whether in negligence or otherwise) arising directly or indirectly from the use of this document is accepted and no representation, warranty or undertaking, express or implied, is or will be made by the Company, or any of its directors, officers, employees, advisers, representatives or other agents ("Agents") for any information or any of the opinions contained herein or for any errors, omissions or misstatements. None of the Agents makes or has been authorised to make any representation or warranties (express or implied) in relation to the Company or as to the truth, accuracy or completeness of this document, or any other written or oral statement provided. In particular, no representation or warranty is given as to the achievement or reasonableness of, and no reliance should be placed on any projections, targets, estimates or forecasts contained in this document and nothing in this document is or should be relied on as a promise or representation as to the future.

Unless otherwise indicated, the information provided herein is based on matters as they exist as of the date of preparation and not as of any future date. Recipients of this document are encouraged to contact the Company's representatives to discuss the procedures and methodologies used to make the projections and other information provided herein.

All investments are subject to risk, including the loss of the principal amount invested. Past performance is not necessarily indicative of future results, and there can be no assurance that BGLF will achieve comparable results, will meet its target returns, achieve its investment objectives or be able to implement its investment strategy. All investments to be held by the Company involve a substantial degree of risk, including the risk of total loss. The value of shares and the income from them is not guaranteed and can fall as well as rise due to stock market and currency movements. When you sell your investment you may get back less than you originally invested. You should always seek expert legal, financial, tax and other professional advice before making any investment decision.

Blackstone Loan Financing Limited is a self-managed Jersey registered alternative investment fund, and is regulated by the Jersey Financial Services Commission as a 'listed fund' under the Collective Investment Funds (Jersey) Law 1988 (the "Funds Law") and the Jersey Listed Fund Guide published by the Jersey Financial Services Commission. The Jersey Financial Services Commission is protected by the Funds Law against liability arising from the discharge of its functions thereunder. The Jersey Financial Services Commission has neither reviewed nor approved the issue of this document.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVKZMMGVLLGFZM
Date   Source Headline
30th Jun 20221:13 pmRNSTransaction in Own Shares
29th Jun 20224:54 pmRNSTransaction in Own Shares
28th Jun 20221:56 pmRNSTransaction in Own Shares
27th Jun 20223:20 pmRNSTransaction in Own Shares
24th Jun 202212:21 pmRNSTransaction in Own Shares
24th Jun 20227:00 amRNSNet Asset Value(s)
23rd Jun 20222:43 pmRNSTransaction in Own Shares
17th Jun 20224:13 pmRNSShare Repurchase Programme
17th Jun 202211:00 amRNSResult of AGM
30th May 20224:50 pmRNSDividend Currency Election
24th May 20227:00 amRNSNet Asset Value and Publication of Monthly Report
12th May 20225:28 pmRNSQ1 2022 Report and Investor Call
6th May 20224:07 pmRNSNotice of AGM
3rd May 20222:56 pmRNSInvestor Call - Replacement
3rd May 202211:52 amRNSInvestor Call
29th Apr 20224:39 pmRNSAnnual Financial Report
25th Apr 20227:00 amRNSNet Asset Value and Publication of Monthly Report
25th Apr 20227:00 amRNSDividend Declaration
21st Apr 20224:21 pmRNSEstimated Net Asset Value
1st Apr 20223:09 pmRNSTotal Voting Rights
23rd Mar 20227:00 amRNSNet Asset Value and Publication of Monthly Report
2nd Mar 202210:00 amRNSDividend Currency Election
1st Mar 20225:10 pmRNSTransaction in Own Shares
1st Mar 20223:02 pmRNSTotal Voting Rights
21st Feb 20227:00 amRNSNet Asset Value(s)
15th Feb 20224:58 pmRNSQ4 2021 Report and Investor Call
11th Feb 20225:15 pmRNSTransaction in Own Shares
1st Feb 20223:49 pmRNSTotal Voting Rights
24th Jan 20224:55 pmRNSTransaction in Own Shares
24th Jan 20227:00 amRNSDividend Declaration and Dividend Policy
24th Jan 20227:00 amRNSNAV, Monthly Report and Investor Call
7th Jan 20224:28 pmRNSTransaction in Own Shares
6th Jan 20225:03 pmRNSTransaction in Own Shares
5th Jan 20224:58 pmRNSTransaction in Own Shares
4th Jan 20225:07 pmRNSTransaction in Own Shares
4th Jan 20223:28 pmRNSTotal Voting Rights
21st Dec 20217:00 amRNSNet Asset Value and Publication of Monthly Report
17th Dec 20215:22 pmRNSTransaction in Own Shares
16th Dec 20215:18 pmRNSTransaction in Own Shares
15th Dec 20215:14 pmRNSTransaction in Own Shares
14th Dec 20214:49 pmRNSTransaction in Own Shares
13th Dec 20215:03 pmRNSTransaction in Own Shares
10th Dec 20215:47 pmRNSTransaction in Own Shares
9th Dec 20215:19 pmRNSTransaction in Own Shares
8th Dec 20215:08 pmRNSTransaction in Own Shares
7th Dec 20215:05 pmRNSTransaction in Own Shares
6th Dec 20214:47 pmRNSTransaction in Own Shares
3rd Dec 20214:56 pmRNSTransaction in Own Shares
1st Dec 20215:01 pmRNSTransaction in Own Shares
1st Dec 20213:57 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.